Embecta (EMBC) Change in Accured Expenses (2020 - 2026)
Embecta (EMBC) posted Change in Accured Expenses of $8.8 million for Q1 2026, up 136.97% sequentially from -$23.8 million in Q4 2025, and up 144.67% YoY from $3.6 million in Q1 2025.
Embecta (EMBC) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Embecta has reported Change in Accured Expenses for 7 years, with the latest figure at $8.8 million in Q1 2026.
- Quarterly Change in Accured Expenses rose 144.67% year-over-year to $8.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$23.4 million (down 2500.0% YoY) and the FY2025 annual result came in at -$68.9 million, down 214.83% from the prior year.
- Change in Accured Expenses rose to $8.8 million in Q1 2026 per EMBC's latest filing, from -$23.8 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $88.4 million in Q2 2022 and troughed at -$45.4 million in Q3 2023.
- A 5-year average of $3.7 million and a median of $3.3 million in 2025 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses slumped 1294.74% in 2023, then jumped 5266.67% in 2024.
- Over 5 years, Change in Accured Expenses stood at $19.4 million in 2022, then plunged by 180.93% to -$15.7 million in 2023, then tumbled by 159.87% to -$40.8 million in 2024, then surged by 41.67% to -$23.8 million in 2025, then jumped by 136.97% to $8.8 million in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered $8.8 million, -$23.8 million, and -$11.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 55.00 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 50.56 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 119.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 50.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 29.00 Mn |
| 10 | Embecta | 305.26 Mn | 87.06 Mn | 153.30 Mn | 16.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.10 Mn |
| Jun 30, 2026 | 16.10 Mn |
| Mar 31, 2026 | 8.80 Mn |
| Mar 31, 2026 | 8.80 Mn |
| Dec 31, 2025 | -23.80 Mn |
| Dec 31, 2025 | -23.80 Mn |
| Sep 30, 2025 | -11.70 Mn |
| Sep 30, 2025 | -11.70 Mn |
| Jun 30, 2025 | 3.30 Mn |
| Jun 30, 2025 | 3.30 Mn |
| Mar 31, 2025 | -19.70 Mn |
| Mar 31, 2025 | -19.70 Mn |
| Dec 31, 2024 | -40.80 Mn |
| Dec 31, 2024 | -40.80 Mn |
| Sep 30, 2024 | 25.50 Mn |
| Sep 30, 2024 | 25.50 Mn |
| Jun 30, 2024 | 34.10 Mn |
| Jun 30, 2024 | 34.10 Mn |
| Mar 31, 2024 | 16.10 Mn |
| Mar 31, 2024 | 16.10 Mn |